Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Roblox's Big Dip: A Chance to Get in on the Vaunted Gaming Stock?

Roblox shares came under pressure as its earnings release disappointed. What is to make of the dip in this renowned gaming stock?

MarketBeat

3 Dividend ETFs to Capitalize on the Slide in Chip Stocks

investors see more demand for AI hardware, which makes these three sector-specific ETFs an attractive way for investors to get exposure to chip stocks

MarketBeat

Is Chevron Stock Primed for Growth After Profit-Boosting News?

Chevron is laying off approximately 20% of its workforce, while it won't be a smooth path, there’s more reason to be bullish than bearish on CVX stock

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

MarketBeat Week in Review – 02/10 - 02/14

Despite many negative headlines, stocks are trading near all-time highs; next week will be a shortened trading week, with most of the monthly economic data in

MarketBeat

3 Consumer Staples ETFs for Stability in a Volatile Market

If the market environment seems a little too uncertain, a risk-averse investor might consider these three consumer staples ETFs to help ride out the turbulence.

MarketBeat

NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment

Shares of WeRide are up over 70% in a single day as a stake from Nvidia is announced, though it may not be what it seems on the surface.

MarketBeat

Up 50% in January, Twilio’s Pullback Is the Time to Buy

Twilio is on track to hit fresh highs this year, the price pullback in February is a buying opportunity that will not likely last long.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Watch These 3 Stocks—High Short Interest and Big Upside Potential

High short interest on a stock that is set to rally is a buyer's dream because it could trigger a short squeeze. Institutional buyers and analysts are in

MarketBeat

Cisco Roars Back: Is the Tech Giant Reborn?

Cisco's strong earnings and shareholder-friendly moves suggest a powerful resurgence, prompting investors to consider if the tech giant is genuinely reborn.

MarketBeat

Albemarle’s Earnings Are In—Is the Stock a Buy Now?

Recently, after reporting its quarterly earnings, shares of Albemarle were slightly up in the after-hours to show investors that there's a new potential upside.

MarketBeat

Forget Tesla: 3 Stocks to Ride the Elon Musk Effect

Here are three stocks that you should consider if you’re looking for ways to invest in companies that may benefit from the Musk effect

MarketBeat

David Tepper Loads Up on China—These 5 Stocks Stand Out

This article covers billionaire hedge fund manager David Tepper's increase of China-related assets to his fund's portfolio and makes 5 stock recommendations.

MarketBeat

Datadog Is in the Doghouse, But This Dip Spells Opportunity

Cybersecurity stock DDOG is pulling back and providing opportunity after tepid guidance sapped investor momentum. The long-term outlook remains intact.

MarketBeat

Vertiv Stock Under Pressure: Is Opportunity Knocking?

Vertiv's recent stock price decline following earnings might be an overreaction, offering a strategic entry point for investors.

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

MicroStrategy’s 8% Preferred Stock: What Investors Should Know

Dive into MicroStrategy's new preferred share offering. Dividend payment details, convertibility and price movement are all vital to understand.

MarketBeat

Biotechs on the Brink: 2 Stocks With Huge Potential

BriaCell Therapeutics and Recursion Pharmaceuticals are two biotech firms that may be poised for success in 2025; risk-tolerant investors might keep an eye out.

MarketBeat

Silicon Valley’s Sleeping Giant? Intel’s Comeback in Focus

Investor enthusiasm is building around Intel as government support and partnership speculation hint at a resurgence for the chip giant.

MarketBeat

Upstart’s Uptrend Is Just Getting Started: Its Time to Load Up

Upstart had a strong end to 2024 and is guiding for momentum in 2025. Revenue is growing at a hyper pace, and institutions and analysts are buying.

Get all your
news in one place.

100’s of premium titles.
One news app.

MarketBeat

Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?

Archer Aviation's new funding will help it advance its project and get production going, but the stock price is unlikely to move higher until late in the year.

MarketBeat

Buffett Buys More Occidental Petroleum—Sticking to His Playbook

After a recent episode of volatility in the stock market, there is one clear sign of where opportunities may still lie for investors.

MarketBeat

CVS Health: Earnings Beat Ignites Stock Rally

CVS Health's stock is showing upward movement after exceeding quarterly earnings expectations, suggesting a potential positive shift.

MarketBeat

Honeywell’s Breakup: Is HON Stock a Sweet Deal for Investors?

Honeywell has announced a split off that will break the company into three separate parts leaving investors to wonder if there's enough value to own HON stock

MarketBeat

PayPal: Time to Strike With Shares Down Double Digits?

PayPal shares took a big hit post earnings. Can the stock recover long-term as it focuses in on a profitable growth strategy?

MarketBeat

Lattice Semiconductor’s Market Reset Is Over: The Rebound Begins

Lattice Semiconductor is turning a corner in 2025 and is positioned to sustain growth long-term as demand for FPGAs is driven by AI and the IoT.

MarketBeat

Will Eli Lilly Stock Keep Climbing? Q2 Trial Results Are Crucial

Eli Lilly is still seeing rapid sales growth for its diabetes and weight loss drugs. However, one drug waiting in the wings hopes to be its next blockbuster.

1 … 80 81 82 83

People

Gabriel OsorioMazilli

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.